SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas - Archive ouverte HAL Access content directly
Journal Articles PLoS ONE Year : 2012

SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas

(1, 2) , (3) , (4) , (5) , (1) , (6) , (7) , (8) , (5) , (9) , (5) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (18) , (19) , (20) , (21) , (22) , (23) , (24) , (25) , (26) , (27, 28) , (29) , (30) , (31) , (32, 33) , (34) , (35, 36, 37) , (8) , (38, 39) , (1, 2) , (5)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Simon de Bernard
  • Function : Author
Luc Bauchet
Elodie Vauleon
  • Function : Author
  • PersonId : 765514
  • IdRef : 113696876
Christine Desenclos
  • Function : Author
  • PersonId : 1149981
  • IdRef : 148178790
Georges Noel
  • Function : Author

Abstract

Anaplastic oligodendrogliomas (AOD) are rare glial tumors in adults with relative homogeneous clinical, radiological and histological features at the time of diagnosis but dramatically various clinical courses. Studies have identified several molecular abnormalities with clinical or biological relevance to AOD (e.g. t(1;19)(q10;p10), IDH1, IDH2, CIC and FUBP1 mutations).To better characterize the clinical and biological behavior of this tumor type, the creation of a national multicentric network, named "Prise en charge des OLigodendrogliomes Anaplasiques (POLA)," has been supported by the Institut National du Cancer (InCA). Newly diagnosed and centrally validated AOD patients and their related biological material (tumor and blood samples) were prospectively included in the POLA clinical database and tissue bank, respectively.At the molecular level, we have conducted a high-resolution single nucleotide polymorphism array analysis, which included 83 patients. Despite a careful central pathological review, AOD have been found to exhibit heterogeneous genomic features. A total of 82% of the tumors exhibited a 1p/19q-co-deletion, while 18% harbor a distinct chromosome pattern. Novel focal abnormalities, including homozygously deleted, amplified and disrupted regions, have been identified. Recurring copy neutral losses of heterozygosity (CNLOH) inducing the modulation of gene expression have also been discovered. CNLOH in the CDKN2A locus was associated with protein silencing in 1/3 of the cases. In addition, FUBP1 homozygous deletion was detected in one case suggesting a putative tumor suppressor role of FUBP1 in AOD.Our study showed that the genomic and pathological analyses of AOD are synergistic in detecting relevant clinical and biological subgroups of AOD.
Fichier principal
Vignette du fichier
journal.pone.0045950.PDF (2.05 Mo) Télécharger le fichier
Origin : Publication funded by an institution
Loading...

Dates and versions

hal-00911465 , version 1 (13-09-2018)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Ahmed Idbaih, François Ducray, Caroline Dehais, Célia Courdy, Catherine Carpentier, et al.. SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS ONE, 2012, 7 (10), pp.e45950. ⟨10.1371/journal.pone.0045950⟩. ⟨hal-00911465⟩
859 View
166 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More